Home » Topics » BioWorld Science

BioWorld Science
RSS

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

Amgen initiates phase IIb trial of tezepelumab for chronic spontaneous urticaria

April 29, 2021

Okyo reports preclinical data with OK-201 in mouse neuropathic corneal pain model

April 29, 2021

Enrollment starts in phase II/III study of BI-767551 in mild to moderate COVID-19

April 29, 2021

Hisamitsu reports phase III results with HP-5070 in primary palmar hyperhidrosis

April 28, 2021

CLES in advanced Parkinson's disease: long-term effects

April 28, 2021

FDA issues complete response letter for pegunigalsidase alfa in Fabry disease

April 28, 2021

Sorrento updates oncology pipeline progress

April 28, 2021

Hillhurst cleared by FDA to begin phase I study of HBI-002 for sickle cell disease

April 28, 2021

Cell death finding may improve stroke management

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...